Tag: Liver
Regorafenib Approved for Hepatocellular Carcinoma
It is the first approved treatment for HCC in almost a decade
Post-RFA Mortality Up for ESRD Patients Who Receive Dialysis
Dialyzed patients have higher in-hospital mortality, hemorrhagic complications after RFA for HCC
Outreach Strategies Increase HCC Screening in Cirrhosis
No difference in proportion undergoing screening with mailed invitation with or without navigation
Sorafenib Effect on HCC Survival Depends on Hepatitis Status
Findings in meta-analysis of individual patient data for advanced unresectable hepatocellular carcinoma
Diabetes Ups Risk of HCC, Death in Patients With Hepatitis C
Diabetes increases risk of hepatocellular carcinoma development in patients with HCV
Outreach Strategies Can Up HCC Screening in Cirrhosis
More patients undergo screening when they receive mailed invitations for screening examination
In Acetaminophen-Induced Acute Liver Failure, FABP1 IDs Mortality
Serum liver-type fatty acid binding protein can discriminate survivors from non-survivors
HOMA2-IR Tied to Hepatocellular Carcinoma Risk in Hepatitis B
HOMA2-IR independently linked to HCC in patients without overt metabolic abnormalities
Weight Loss May Not Benefit Colon, Liver Cancer
In experimental study, no impact on colon tumorigenesis; may negatively impact liver repair
High BMI, Large Waist, T2DM Tied to Increased Odds of Liver Cancer
Study adds support to liver cancer as an obesity-associated cancer
